Results from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast reduction) Trial

Sponsored by Philips

Summary

Javier Escaned joins Ajay Kirtane to discuss the DCR4C Trial he conducted, and more specifically to present the main results.

The framework of the study was the contrast reduction during PCI, which is closely related to what is now known as ultra-low contrast PCI, and which mainly concerns particularly sensitive patients. Its aim was to analyze the efficacy of the dynamic coronary roadmapping to reduce contrast administration during PCI.

Find out more about the design, outcomes and impact of this trial in this video!

This interview was filmed at EuroPCR 2023: see more videos here!